Dr. Anand Kumar Saxena is a senior neurologist with over two decades of experience across leading hospitals in Delhi. He specializes in stroke management, movement disorders, neuroimmunology, and neuromuscular diseases, with extensive expertise in administering Botox injections for dystonia and post-stroke spasticity. His leadership roles across multiple institutions reflect his strong academic foundation and commitment to clinical excellence. He is widely recognized for delivering patient-focused neurological care supported by evidence-based practices and advanced treatment techniques.

Educational Qualifications:

• DM (Neurology) – GB Pant Hospital, New Delhi (2006)
• MD (General Medicine) – SMS Medical College, Jodhpur (1994)
• MBBS – Maulana Azad Medical College, New Delhi (1989)

Professional Experience:

• Principal Director & Unit Head – Neurology, Max Healthcare (Current)
• HOD & Director – Neurology, Venkateshwara Hospital, Dwarka (2021–2024)
• Director & Head – Neurology, Max Smart Super Speciality Hospital, New Delhi (2013–2021)
• Associate Director – Neurology, BLK Super Speciality Hospital (2009–2013)
• Visiting Consultant – Max Hospital, Gurgaon (2008–2009)
• Visiting Consultant – Columbia Asia Hospital, Gurgaon (2008–2009)
• Visiting Consultant – Umkal Multispeciality Hospital (2008–2009)
• Consultant – Mata Chanan Devi Hospital, New Delhi (2008–2009)
• Consultant – Indian Spinal Injuries Centre, Vasant Kunj (2006–2008)

Awards & Achievements:

• Winner – ‘Around The World’ Contest
• Star Performer – Saket City Hospital (2015)
• Star Performer Award – BLK Super Speciality Hospital
• Invited Speaker at Multiple National Conferences

Professional Memberships:

• Indian Stroke Association
• Indian Academy of Neurology
• Delhi Neurological Association
• Nerve & Muscle Disorder Society

Research Papers & Publications:

• Poster – Radiation Leukoencephalopathy (NSI, 2004)
• Paper – Comparative Study of Anxiety & Depression in Controlled vs Uncontrolled Epilepsy (NSI, 2006)
• Poster – Stiffed Muscle with Stiff Heart, GAD65+ (25th DNACON)
• International Multicentric Drug Trial in NMO